Skip to main content
. 2022 Jan 25;3(7):e543–e552. doi: 10.1016/S2666-5247(21)00237-8

Figure 2.

Figure 2

Survival estimation of COVID-19-associated mucormycosis cases

Kaplan-Meier survival estimation for patients with rhino-orbital cerebral disease without CNS involvement, rhino-orbital cerebral mucormycosis with CNS involvement, and other forms of mucormycosis (eg, pulmonary, gastrointestinal, and disseminated). HR=hazard ratio.